Alterola Biotech (ABTI) Stock Statistics & Valuation Metrics
Total Valuation
Alterola Biotech has a market cap or net worth of $291.90K. The enterprise value is $8.85T.
- Market Cap
- $291.90K
- Enterprise Value
- $8.85T
Share Statistics
Alterola Biotech has 1,459,502,100 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,459,502,100
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Alterola Biotech’s return on equity (ROE) is -0.15 and return on invested capital (ROIC) is -14.98%.
- Return on Equity (ROE)
- -0.15
- Return on Assets (ROA)
- -0.12
- Return on Invested Capital (ROIC)
- -14.98%
- Return on Capital Employed (ROCE)
- -0.19
- Revenue Per Employee
- 0
- Profits Per Employee
- -1.54M
- Employee Count
- 1
- Asset Turnover
- 0.00
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Alterola Biotech is -0.11. Alterola Biotech’s PEG ratio is -0.00.
- PE Ratio
- -0.11
- PS Ratio
- 0.00
- PB Ratio
- 0.02
- Price to FCF
- -0.25
- Price to Operating Cash Flow
- -0.16
- PEG Ratio
- -0.00
Income Statement
In the last 12 months, Alterola Biotech had revenue of 0 and earned -1.54M in profits. Earnings per share was -0.00.
- Revenue
- 0
- Gross Profit
- 0
- Operating Income
- -1.90M
- Pretax Income
- -1.70M
- Net Income
- -1.54M
- EBITDA
- 135.87K
- Earnings Per Share (EPS)
- -0.00
Cash Flow
In the last 12 months, operating cash flow was -874.20K and capital expenditures -18,900, giving a free cash flow of -893.10K billion.
- Operating Cash Flow
- -874.20K
- Free Cash Flow
- -893.10K
- Free Cash Flow per Share
- -0.00
Dividends & Yields
Alterola Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -404.11%
- Earnings Yield
- -956.46%
Stock Price Statistics
- Beta
- -20.47
- 52-Week Price Change
- 0.00%
- 50-Day Moving Average
- 0.20
- 200-Day Moving Average
- 0.20
- Relative Strength Index (RSI)
- ―
- Average Volume (3m)
- ―
Financial Position
Alterola Biotech as a current ratio of 0.11, with Debt / Equity ratio of 14.01%
- Current Ratio
- 0.11
- Quick Ratio
- 0.11
- Debt to Market Cap
- 0.04
- Net Debt to EBITDA
- -0.83
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Alterola Biotech has paid -154.52K in taxes.
- Income Tax
- -154.52K
- Effective Tax Rate
- 0.09
Enterprise Valuation
Alterola Biotech EV to EBITDA ratio is 12.50, with an EV/FCF ratio of -1.44.
- EV to Sales
- 0.00
- EV to EBITDA
- 12.50
- EV to Free Cash Flow
- -1.44
- EV to Operating Cash Flow
- -1.63
Balance Sheet
Alterola Biotech has $9,102.00 in cash and marketable securities with $1.55M in debt, giving a net cash position of -$1.54M billion.
- Cash & Marketable Securities
- $9,102.00
- Total Debt
- $1.55M
- Net Cash
- -$1.54M
- Net Cash Per Share
- $0.00
- Tangible Book Value Per Share
- $0.00
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
- Gross Margin
- 0.00%
- Operating Margin
- 0.00%
- Pretax Margin
- 0.00%
- Net Profit Margin
- 0.00%
- EBITDA Margin
- 0.00%
- EBIT Margin
- 0.00%
Analyst Forecast
The average price target for Alterola Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- 0
- Revenue Growth Forecast
- ―
- EPS Growth Forecast
- ―